Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Spevigo 450 mg concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
spesolimab
Company:  
Boehringer Ingelheim Limited See contact details
ATC code: 
L04AC22
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 01 Nov 2023

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Boehringer Ingelheim Limited
Company image
Address
Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
WWW
http://www.boehringer-ingelheim.co.uk
Telephone
+44 (0)1344 424 600
Fax
01344 741444
Medical Information Direct Line
+44 (0)1344 742579
Medical Information e-mail
[email protected]